Maciej Banach, Agnieszka Mastalerz–Migas, Krystian Wita, Małgorzata Myśliwiec
In the last decade, Poland has introduced various healthcare programs and initiatives aimed at effectively managing and preventing lipid disorders, a leading risk factor for cardiovascular disease (CVD) affecting as many as 70 % of the population. Education plays a vital role, with the "Health Education" subject introduced in schools, patient education integrated into primary and secondary prevention programs, and lipidology certification available for healthcare professionals. Screening programs like "My Health" offer comprehensive health assessments, including lipid profiles and the first universal lipoprotein(a) screening for individuals aged 20 and older. A universal screening program for familial hypercholesterolemia (FH) has also been implemented for children at the age of 6. The KOS-Zawał program provides comprehensive, highly effective cardiology care for post-myocardial infarction patients. Additionally, recent results from the B101 drug program demonstrate unprecedented effectiveness of combination lipid-lowering therapy with PCSK9 inhibitors for patients with lipid disorders. These programs aim to improve early diagnosis, enhance therapy adherence, and ensure access to innovative treatments, ultimately reducing cardiovascular mortality. They may also serve as a valuable example for other countries looking to effectively prevent and combat this prevalent CVD risk factor.